Compare COFS & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COFS | EOLS |
|---|---|---|
| Founded | 1898 | 2012 |
| Country | United States | United States |
| Employees | 598 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.2M | 407.0M |
| IPO Year | 1995 | 2018 |
| Metric | COFS | EOLS |
|---|---|---|
| Price | $31.45 | $6.57 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $34.00 | $15.50 |
| AVG Volume (30 Days) | 54.0K | ★ 911.5K |
| Earning Date | 04-24-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.86% | N/A |
| EPS Growth | N/A | ★ 1.23 |
| EPS | ★ 0.91 | N/A |
| Revenue | $227,624,000.00 | ★ $297,176,000.00 |
| Revenue This Year | $22.13 | $13.27 |
| Revenue Next Year | $4.47 | $17.62 |
| P/E Ratio | $34.42 | ★ N/A |
| Revenue Growth | ★ 63.64 | 11.61 |
| 52 Week Low | $26.10 | $3.86 |
| 52 Week High | $33.58 | $10.62 |
| Indicator | COFS | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 63.90 |
| Support Level | $29.51 | $6.44 |
| Resistance Level | $32.43 | $6.66 |
| Average True Range (ATR) | 0.68 | 0.29 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 67.05 | 75.50 |
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.